LinkOPH

Aggregated links in Ophthalmology

Main menu

Skip to content
  • Home
  • Blogs
  • Podcasts
  • Video
  • Clinical Trials
  • Peer-reviewed
  • Twitter
  • About

Sub menu

  • Refractive
    • Optic
  • Cornea
    • Conjunctiva
  • Glaucoma
  • Cataract
  • Retina
  • Uveitis
  • Infectious
  • Pediatrics
  • Neuro
  • Business
Uncategorized

NextGen Healthcare Introduces N.I.A.™ for Insights, an Analytics Agent That Helps Healthcare Organizations Make Decisions Faster

by Business Wire • 2026/10/21

SAN DIEGO–(BUSINESS WIRE)– #NextGenHealthcare–NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, today announced N.I.A.™ (NextGen Intelligent Agent) for Insights, an analytics agent built directly into…

Read more →

Uncategorized

NextGen Healthcare Introduces N.I.A.™ for Insights, an Analytics Agent That Helps Healthcare Organizations Make Decisions Faster

by Business Wire • 2026/10/21

SAN DIEGO–(BUSINESS WIRE)– #NextGenHealthcare–NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, today announced N.I.A.™ (NextGen Intelligent Agent) for Insights, an analytics agent built directly into…

Read more →

Uncategorized

NextGen Healthcare Introduces N.I.A.™ for Insights, an Analytics Agent That Helps Healthcare Organizations Make Decisions Faster

by Business Wire • 2026/10/21

SAN DIEGO–(BUSINESS WIRE)– #NextGenHealthcare–NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, today announced N.I.A.™ (NextGen Intelligent Agent) for Insights, an analytics agent built directly into…

Read more →

News

Viral Culprit Behind Unexpected Eye Cases

by Medscape • 2026/10/21

Herpesviruses may underlie ocular conditions in ways that defy clinicians’ expectations. Medscape Medical News

Read more →

Uncategorized

Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2

by Business Wire • 2026/10/20

GENEVA–(BUSINESS WIRE)–Alcon Acquires Neurotech and ENCELTO, the Only FDA Approved Treatment for MacTel Type 2

Read more →

Uncategorized

Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2

by Business Wire • 2026/10/20

GENEVA–(BUSINESS WIRE)–Alcon Acquires Neurotech and ENCELTO, the Only FDA Approved Treatment for MacTel Type 2

Read more →

Page 3 of 8114
« 1 2 3 4 5 … 8,114 »

Tags

Anesthesiology Article Cardiac Surgery Cardiology Clinical Summary Commentary Critical Care Dermatology Diabetes & Endocrinology Diagnostics Emergency Medicine ENT Exclusive Eye Health / Blindness Family Medicine/Primary Care Genetics GI Informatics Internal Medicine Journal Article Materials Medicine Nanomedicine Neurology Neurosurgery News News Alert Ob/Gyn Oncology Ophthalmology Orthopedic Surgery Pathology Pediatrics Plastic Surgery Psychiatry Public Health Radiology Rehab Sports Medicine surgery Telemedicine Thoracic Surgery Urology Vascular Surgery Viewpoint

Archives

Sources

  • Advanced Ocular Care – Issues
  • Advanced Ocular Care – News
  • Business Wire
  • Business Wire Health: Optical News
  • Cataract & Refractive Surgery Today – Issues
  • Cataract & Refractive Surgery Today – News
  • Clinical Trials Updates
  • EyeDocNews Blog
  • Eyewire Today
  • Healio
  • IOVS/SciVee
  • Irv Arons' Journal
  • Medgadget
  • Medical News Today
  • MedicineWorld
  • MedPage Today
  • Medscape
  • Medscape Ophthalmology Podcast
  • MedscapeCME Ophthalmology Podcast
  • ModernMedicine – Ophthalmology
  • NeLM – Ophthalmology
  • NHS Evidence
  • Ophthalmology Update
  • OphthalmologyWeb
  • OphthalmologyWeb Videos
  • OphthoBook (videos)
  • RetinaEyeDoctor.com
  • Root Atlas
  • ScienceDaily
  • The Medical News

Copyright © 2026 LinkOPH. All Rights Reserved. The Magazine Basic Theme by bavotasan.com.